Pharma Marketing Network

SEPTEMBER 22, 2021

Licensed Clinical Psychologist, Clinical Director, Virtual Counselor/College Telehealth. Recent shifts in rep access, HCP media preferences and the emergence of new data-driven platforms have forced pharmaceutical and life science organizations to accelerate their digital transformation. Reena Kolar , Ph.D,

Big Data 52

Big Data Marketing Life Science Licensing 52

Pharma Marketing Network

SEPTEMBER 22, 2021

Licensed Clinical Psychologist, Clinical Director, Virtual Counselor/College Telehealth. Recent shifts in rep access, HCP media preferences and the emergence of new data-driven platforms have forced pharmaceutical and life science organizations to accelerate their digital transformation. Reena Kolar , Ph.D,

Big Data 40

Big Data Marketing Life Science Licensing 40

pharmaphorum

OCTOBER 16, 2020

These might be licensed drugs that could hold potential for a patent extension, or drugs which failed efficacy trials for an intended indication. In the quest to repurpose a drug for a rare condition, there is a need to look at any and all available data. The post Rare diseases, repurposing and the role of AI appeared first on.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Life Science 105

Drug Discovery World

OCTOBER 12, 2022

DDW sits down with Mark Matson, Senior Solution Specialist for Sensor Cloud at Medidata, a Dassault Systèmes company, about the use of digital biomarkers in life sciences and how they can help advance our understanding of disease. . How do we define digital biomarkers? . About the author .

Clinical Trials 52

Clinical Trials Clinical Trials Trials Sales 52

pharmaphorum

SEPTEMBER 18, 2020

Meanwhile, the search for the ‘right target’ led the company to collaborate with Cancer Research UK and launch the Functional Genomics Centre , a centre of excellence for genetic screening, cancer modelling and big data processing aimed at accelerating the discovery of new cancer medicines, including those based on CRISPR technology.

Pharma Companies 116

Pharma Companies Sales Vaccination Vaccine 116

Drug Discovery World

SEPTEMBER 6, 2022

The use of big data and AL to direct the best patient candidates for CGT and to provide the best understanding of efficacy and benefits.” – ? The Skills Demand Survey Report presents a lack of graduate life sciences apprenticeship programmes as a key barrier. Chris Nowers, CEO, ONK Therapeutics. . “ Workforce .

Gene Therapy 52

Gene Therapy Gene Manufacturing Medicine 52

XTalks

AUGUST 2, 2023

Late in 2022, AbbVie partnered with HotSpot Therapeutics and announced an exclusive worldwide collaboration and option to license agreement for their interferon regulatory factor 5 (IRF5) inhibitor program for autoimmune disease treatment. In 2022, the FDA proceeded to grant official licensing for Moderna’s Spikevax COVID-19 vaccine.

Sales 98

Sales Manufacturing FDA Approval Life Science 98